Paul Tudor Jones’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Paul Tudor Jones’s Portfolio OSIR Stock Details OSIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-101,788	Closed	-$489K	–	1621
2017 Q1	$489K	Buy	+101,788	New	+$553K	0.02%	703
2014 Q1	–	Sell	-12,466	Closed	-$200K	–	1623
2013 Q4	$200K	Buy	+12,466	New	+$199K	0.01%	1111

Other funds holding OSIR

FIM

Freedom Investment Management Hartford, Connecticut $359M AUM 23.01% 1-Year Est. Return

Public Employees Retirement Association of Colorado Denver, Colorado $28.9B AUM 44.1% 1-Year Est. Return

MAM

Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

Paul Tudor Jones's OSIR Position: Q2 2017 in Review

Paul Tudor Jones sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q2 2017, closing a stake of 101,788 shares — an estimated $489K sold.

Paul Tudor Jones first reported a position in OSIR in Q4 2013 and held it in 2 quarters. The position peaked at $489K in Q1 2017. 3 funds tracked by Wall St. Rank hold OSIR as of Q2 2017.

Paul Tudor Jones reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q2 2017 after selling out during the quarter.
Paul Tudor Jones sold 101,788 Osiris Therapeutics, Inc. Common Stock shares in Q2 2017, an estimated $489K.
Paul Tudor Jones first reported a position in Osiris Therapeutics, Inc. Common Stock in Q4 2013 and held it in 2 quarters.
Paul Tudor Jones's Osiris Therapeutics, Inc. Common Stock position peaked at $489K in Q1 2017.
3 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q2 2017.

Based on Tudor Investment Corp's 13F filing for Q2 2017, filed 14 Aug 2017.